Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/10/24 13:22
2014/10/24 13:22
7h
Stuart A. writes: "Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk about the issues that might be raised there?" The Food and Drug Administration is...
2014/10/24 13:22
2014/10/24 13:22
Latest videos
2014/10/23 14:22
2014/10/23 14:22
1d
TEL AVIV, Israel ( TheStreet) -- Alcobra(ADHD) disclosed in a regulatory filing Wednesday night new details about the phase III study of attention-deficit hyperactivity disorder drug candidate MDX...
2014/10/21 10:22
2014/10/21 10:22
3d
Mapp already has a manufacturing partner for ZMapp -- Kentucky BioProcessing, a unit of the diversified industrial, Reynolds American(RAI) . Let's assume that Mapp and Kentucky BioProcessing part ways...
2014/10/17 23:22
2014/10/17 23:22
6d
NEW YORK (TheStreet) -- Shares of Sarepta Therapeutics(SRPT) are soaring this morning following the publication of Phase I clinical study results for its Ebola and Marburg virus drug candidates....
2014/10/16 13:22
2014/10/16 13:22
8d
NEW YORK (TheStreet) -- Halfway through my two-hour phone conversation with Tony Fiorino last week, I asked the health care hedge fund investor-turned-CEO of Brainstorm Cell Therapeutics(BCLI) why he...
2014/10/10 19:22
2014/10/10 19:22
14d
Gilead Sciences(GILD) has secured U.S. approval for Harvoni, a new combination hepatitis C therapy, according to an announcement by the U.S. Food and Drug Administration. Harvoni is a single,...
2014/10/10 18:22
2014/10/10 18:22
14d
Gilead Sciences(GILD) has secured U.S. approval for Harvoni, a new combination hepatitis C therapy, according to an announcement from the U.S. Food and Drug Administration. Harvoni is a single,...
2014/10/10 11:22
2014/10/10 11:22
14d
Industry Recommendation: Crosswalk to Code 81315 (PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common...
2014/10/08 20:42
2014/10/08 20:42
15d
While I was finishing my morning post on brincidofovir’s preliminary efficacy in immunocompromised patients with adenoviral infections, the announcement came that Thomas Eric Duncan had succumbed to...
2014/10/08 12:22
2014/10/08 12:22
16d
BOSTON ( TheStreet) -- Washington Post business columnist Steven Pearlstein accused me -- falsely -- of working with short-selling hedge funds to manipulate stock prices and force small biotech...
2014/10/06 19:22
2014/10/06 19:22
18d
Updated from 6:38 am ET with additional information. TEL AVIV (TheStreet) -- Treatment with an experimental formulation of vitamin B6 known as MDX failed to improve the symptoms of attention-deficit...
2014/10/06 11:22
2014/10/06 11:22
18d
SOUTH SAN FRANCISCO ( TheStreet) -- Sunesis Pharmaceuticals(SNSS) announced the failure of a phase III study Monday morning. The company's experimental drug vosaroxin did not extend survival of...
2014/10/06 11:22
2014/10/06 11:22
18d
Note: This article discusses one or more stocks with a market cap between $350 million and $2 billion. Such small-cap stocks tend to be volatile. NEW YORK (TheStreet) -- Imagine being jet lagged for...
2014/10/01 14:22
2014/10/01 14:22
23d
NEW YORK ( TheStreet) -- Ebola is here, so for daytraders of biotech and drug stocks, Wednesday is going to be their Best. Day. Ever. A guy traveling from Liberia to Dallas was diagnosed with the...
2014/09/30 11:22
2014/09/30 11:22
24d
Catalyst reported positive results from a phase III study of Firdapse as a treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a progressive, muscle-weakening disease. Treatment with Firdapse...
2014/09/29 14:22
2014/09/29 14:22
25d
In the study (known as AETHERA), treatment with Adcetris in "high risk" Hodgkin lymphoma patients immediately after a stem-cell transplant led to a 43% reduction in the risk of disease progression...
2014/09/27 22:19
2014/09/27 22:19
26d
The past couple of weeks should have been heady ones for Bethesda-based Northwest Biotherapeutics. The small biotech firm, with an innovative new vaccine treatment for brain, prostate and other...
2014/09/26 11:22
2014/09/26 11:22
28d
The next big pipeline event from Vertex is the phase II study of VX-661 in homozygous F508del cystic fibrosis patients. Data expected early next year. Again, I'm hearing Vertex management sounds...
2014/09/24 13:22
2014/09/24 13:22
30d
BOSTON ( TheStreet) -- Adam, since you like talking to yourself about biotech stocks, I was hoping you could help me figure out Alcobra(ADHD) . The announcement of results from the phase III study of...
2014/09/22 17:22
2014/09/22 17:22
m
FOSTER CITY, Calif. ( TheStreet) -- Gilead Sciences(GILD) has been on an incredible stock-flying run because of its hepatitis C drugs, but now you're telling me investors are swinging their attention...
2014/10/24 13:22
2014/10/24 13:22
Latest from Twitter